Studies on Renal Disorders /
Corporate Author: | |
---|---|
Other Authors: | , , |
Format: | eBook |
Language: | English |
Published: |
Totowa, NJ :
Humana Press : Imprint: Humana,
2011.
|
Edition: | 1st ed. 2011. |
Series: | Oxidative Stress in Applied Basic Research and Clinical Practice,
|
Subjects: |
Table of Contents:
- Preface
- Chapter 1. Oxidative stress injury in glomerular mesangium
- Chapter 2. Transition Metals and other Forms of Oxidative Protein Damage in
- Renal Disease
- Chapter 3. Cyclo-oxygenase in the kidney and oxidative stress
- Chapter 4. Renin angiotensin system in the kidney and oxidative stress -Local Renin-Angiotensin-Aldosterone-System and NAD(P)H oxidase-dependent oxidative stress in the kidney-
- Chapter 5. Thiamine in diabetic renal disease - dietary insufficiency, renal
- washout, anti-stress gene response, therapeutic supplements, risk predictor and link to genetic susceptibility
- Chapter 6. Novel members of the globin family and their function against oxidative stress
- Clinical Aspects of Oxidative Stress in the Kidney
- Chapter 7. Hypertension
- Chapter 8. Uric acid and oxidative stress
- Chapter 9. Reactive oxygen and nitrogen species, oxidative and nitrosative
- stress and their role in the pathogenesis of acute kidney injury
- Chapter 10. Oxidative stress in the kidney: proximal tubule disorders
- Chapter 11. Iron metabolism and oxidative stress
- Chapter 12. Hypoxia, oxidative stress and the pathophysiology of contrast-media-induced nephropathy
- Chapter 13. Cardiovascular complications in renal failure: implications of advanced glycation end-products and their receptor, RAGE
- Chapter 14. Infection and the kidney
- Chapter 15. Oxidative/carbonyl stress in the renal circulation and cardiovascular renal injury
- Current Therapy Targeting Oxidative Stress
- Chapter 16. Renin angiotensin system
- Chapter 17. Oxidative stress in kidney injury-peroxisome proliferator-activated receptor- agonists are in control
- Chapter 18. Statin
- Chapter 19. N-acetylcysteine in kidney disease
- Chapter 20. Advanced glycation end products (AGEs) inhibitor
- Section 2. 'Hypoxia'
- Hypoxia Biology
- Chapter 21. Involvement of hypoxia-inducible factor 1 in physiological and pathological responses to continuous and intermittent hypoxia: Role of reactive oxygen species
- Chapter 22. Regulation of oxygen homeostasis by PHDs
- Chapter 23. Oxygen-dependent regulation of erythropoiesis
- Chapter 24. Intricate link between hypoxia and oxidative stress in chronic kidney disease
- Chapter 25. RNA interference and the regulation of renal gene expression in
- hypoxia
- Hypoxia Pathology in Renal Disorders
- Chapter 26.Cardio-renal connection: The role of hypoxia and oxidative stress
- Chapter 27. HIF in acute kidney injury - from pathophysiology to a novel approach of organ protection
- Chapter 28. Hypoxia in chronic kidney disease: the final common pathway to end stage renal disease
- Chapter 29. Oxidative stress and hypoxia in the pathogenesis of diabetic
- nephropathy
- Chapter 30. Estimation of kidney oxygenation by BOLD-MRI
- Chapter 31. Anemia and progression of chronic kidney disease
- Section 3. Novel therapeutic approaches against oxidative stress and hypoxia
- Chapter 32. Novel therapeutic approaches against hypoxia and oxidative stress,targeting intracellular sensor molecules for oxygen and oxidative stress
- Chapter 33. Endoplasmic reticulum (ER) stress as a target of therapy against oxidative stress and hypoxia
- Chapter 34. Stem cell therapy against oxidative stress and hypoxia.